VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $59,000 | -96.8% | 1,530 | -96.9% | 0.00% | -100.0% |
| Q2 2020 | $1,817,000 | -80.0% | 49,551 | -87.4% | 0.00% | -83.3% |
| Q1 2020 | $9,070,000 | +75.4% | 393,646 | +122.9% | 0.01% | +140.0% |
| Q4 2019 | $5,171,000 | -42.3% | 176,600 | -49.6% | 0.01% | -37.5% |
| Q2 2019 | $8,964,000 | +42.0% | 350,705 | +24.5% | 0.01% | +33.3% |
| Q1 2019 | $6,314,000 | -2.7% | 281,625 | -8.5% | 0.01% | -14.3% |
| Q4 2018 | $6,489,000 | +80.6% | 307,705 | +91.0% | 0.01% | +133.3% |
| Q2 2018 | $3,594,000 | -16.9% | 161,105 | -18.1% | 0.00% | -25.0% |
| Q1 2018 | $4,323,000 | -43.1% | 196,700 | -40.5% | 0.00% | -42.9% |
| Q3 2017 | $7,592,000 | +75.1% | 330,660 | +68.3% | 0.01% | +75.0% |
| Q2 2017 | $4,337,000 | -52.1% | 196,420 | -42.6% | 0.00% | -55.6% |
| Q3 2016 | $9,046,000 | -2.1% | 342,253 | +2.6% | 0.01% | -10.0% |
| Q2 2016 | $9,242,000 | – | 333,515 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |